← All companies
AMLX annual net income
Amylyx Pharmaceuticals, Inc.
AMLX - CIK 0001658551
Market cap$1.48 B
Rank#2327
SEC filings403
Amylyx Pharmaceuticals, Inc. net income by year
Amylyx Pharmaceuticals, Inc. (AMLX) reported net income of -$144.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
AMLX net income 2021-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$144.74M | +52.0% |
| FY 2024 | -$301.74M | -712.4% |
| FY 2023 | $49.27M | +124.8% |
| FY 2022 | -$198.38M | -125.6% |
| FY 2021 | -$87.93M | - |
Net Income of similar companies
Frequently asked questions
How much profit does Amylyx Pharmaceuticals, Inc. make?
Amylyx Pharmaceuticals, Inc. (AMLX) reported net income of -$144.74M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Amylyx Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2021 and fiscal 2025, Amylyx Pharmaceuticals, Inc.'s net income declined from -$87.93M to -$144.74M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.